No abstract available
MeSH terms
-
Adenocarcinoma of Lung* / drug therapy
-
Adenocarcinoma of Lung* / genetics
-
Adenocarcinoma of Lung* / pathology
-
Adenocarcinoma* / drug therapy
-
Adenocarcinoma* / genetics
-
Adenocarcinoma* / pathology
-
Anaplastic Lymphoma Kinase* / antagonists & inhibitors
-
Anaplastic Lymphoma Kinase* / genetics
-
Crizotinib / pharmacology
-
Crizotinib / therapeutic use
-
Female
-
Humans
-
Lung Neoplasms* / drug therapy
-
Lung Neoplasms* / genetics
-
Lung Neoplasms* / pathology
-
Male
-
Middle Aged
-
Oncogene Proteins, Fusion* / genetics
-
Protein Kinase Inhibitors* / pharmacology
-
Protein Kinase Inhibitors* / therapeutic use
-
Receptor Protein-Tyrosine Kinases / genetics
Substances
-
Anaplastic Lymphoma Kinase
-
ALK protein, human
-
Protein Kinase Inhibitors
-
Oncogene Proteins, Fusion
-
Receptor Protein-Tyrosine Kinases
-
Crizotinib